NOVN
Novartis AG insider transactions
Healthcare · SIX · Switzerland
Net insider signal · last quarter
Selling
Share price & insider trades · last quarter ▲ buy ▼ sell
CHF 130.6 CHF 106.6 10 Apr 09 Jul
Insiders were sellers over the last quarter — 1 sale, no buys — a net CHF 611K of selling. Most recent filing: 18 May 2026.
Net insider flow · last quarter
-CHF 611K 0 buys · 1 sells
Insider profiles
+●.●% avg 3m · win rate
Transactions
18 May 2026 Management Sell CHF 611,021 06 Feb 2026 Management Sell CHF 9,551,906 06 Feb 2026 Management Sell CHF 3,595,685
05 Feb 2026 Management ▼ Sell CHF 7,865,330
05 Feb 2026 Management ▼ Sell CHF 2,505,996
28 Jan 2026 Management ▲ Buy CHF 355,390
07 Nov 2025 Management ▼ Sell CHF 2,034,354
30 Oct 2025 Management ▼ Sell CHF 246,319
16 Sep 2025 Management ▼ Sell CHF 252,610
19 Aug 2025 Management ▼ Sell CHF 3,015,378
13 Aug 2025 Management ▼ Sell CHF 190,440
13 Aug 2025 Management ▼ Sell CHF 337,699
16 Jun 2025 Management ▼ Sell CHF 422,701
03 Jun 2025 Management ▼ Sell CHF 13,076,556
30 Apr 2025 Management ▼ Sell CHF 1,973,994
11 Feb 2025 Management ▼ Sell CHF 312,203
07 Feb 2025 Management ▼ Sell CHF 2,500,279
05 Feb 2025 Management ▼ Sell CHF 1,365,687
04 Feb 2025 Management ▼ Sell CHF 1,840,201
30 Jan 2025 Management ▲ Buy CHF 699,425
30 Jan 2025 Management ▲ Buy CHF 698,883
Showing older filings · the 3 most recent are subscriber-only
Under the EU Market Abuse Regulation (MAR), executives and board members (PDMRs) at Swiss-listed companies must disclose dealings in their company's shares to SIX. Insider Transaction Terminal aggregates these filings daily, filters out the noise and gives you the trades that actually matter.